fda d.i.s.c.o. burst edition: fda approval of augtyro (repotrectinib) for locally advanced or met...
Published 6 months ago • 146 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
5:01
fda d.i.s.c.o. burst edition: fda approvals of augtyro (repotrectinib) for ntrk gene fusion-posit...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of cabometyx (cabozantinib) for locally advanced or me...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) for adult patients with previo...
-
6:31
fda d.i.s.c.o. burst edition: approval of padcev (enfortumab vedotin-ejfv) for locally advanced o...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of retevmo (selpercatinib) for advanced or metastatic ...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of lynparza (olaparib), with abiraterone and prednison...
-
3:31
fda d.i.s.c.o. burst edition: libtayo (cemiplimab-rwlc) for patients with locally advanced or met...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for patients with metastat...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of scemblix (asciminib) for patients with philadelphia...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with lenvim...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of trodelvy (sacituzumab govitecan-hziy) for hr-positi...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of imfinzi (durvalumab) for adult patients with locall...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of fruzaqla (fruquintinib) for adult patients with met...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of padcev (enfortumab vedotin-ejfv) with keytruda (pem...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of libtayo (cemiplimab-rwlc) in combination with plati...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of carvykti (ciltacabtagene autoleucel) for the treatm...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of rezlidhia (olutasidenib) for relapsed or refractor...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of epkinly (epcoritamab-bysp) for relapsed or refracto...
-
5:31
fda d.i.s.c.o. burst edition: fda approvals of trodelvy (sacituzumab govitecan) for locally advan...